Gene: YTHDF1
Official Full Name: YTH N6-methyladenosine RNA binding protein F1provided by HGNC
Gene Summary: Enables N6-methyladenosine-containing RNA reader activity and ribosome binding activity. Involved in mRNA destabilization; positive regulation of translational initiation; and stress granule assembly. Located in P-body and cytoplasmic stress granule. Implicated in colorectal cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00994 | YTHDF1 Knockout cell line (A549) | Human | YTHDF1 | 1:3~1:4 | Negative | Online Inquiry |
KO09339 | YTHDF1 Knockout cell line (HeLa) | Human | YTHDF1 | 1:3~1:6 | Negative | Online Inquiry |
KO09340 | YTHDF1 Knockout cell line (HCT 116) | Human | YTHDF1 | 1:2~1:4 | Negative | Online Inquiry |
KO09341 | YTHDF1 Knockout cell line (HEK293) | Human | YTHDF1 | 1:3~1:6 | Negative | Online Inquiry |
YTHDF1 Gene Knockout Cell Lines represent a cutting-edge tool for researchers investigating RNA methylation dynamics and their implications in various biological processes. These cell lines have been specifically engineered to lack the expression of the YTHDF1 gene, which encodes a member of the YTH domain family of proteins that play a crucial role in recognizing N6-methyladenosine (m6A) modifications on mRNA. By removing the YTHDF1 protein, these knockout cell lines enable the study of its functions in mRNA stability, translation regulation, and gene expression, providing a valuable model for dissecting the biological consequences of altered m6A signaling.
The functional mechanisms underlying YTHDF1 action are multifaceted; it interacts with transcripts containing m6A modifications and modulates their turnover and translation efficiency. Understanding these pathways is vital, as dysregulation of m6A methylation has been implicated in cancer progression, neurodevelopmental disorders, and other diseases. Thus, utilizing YTHDF1 Knockout Cell Lines allows researchers to explore the mechanistic basis of these diseases at a cellular level, leading to potential therapeutic innovations.
One of the standout advantages of our YTHDF1 Gene Knockout Cell Lines is their precision and reliability, as they are produced through advanced CRISPR-Cas9 genome-editing techniques which ensure complete deletion of the target gene without off-target effects. This level of specificity not only enhances reproducibility in experiments but also sets our product apart from chemically-induced or transient knockdown alternatives that often have variable outcomes.
For researchers and clinicians focused on cellular mechanisms of disease, these knockout cell lines are invaluable for elucidating the roles of m6A modifications in gene expression regulation. By offering a robust and versatile system for studying RNA biology, our YTHDF1 Gene Knockout Cell Lines empower innovative research efforts while opening pathways to novel diagnostic and therapeutic strategies.
With a commitment to quality and scientific excellence, our company specializes in providing high-fidelity cellular models and gene-editing solutions designed to accelerate discoveries in molecular and cellular biology. We bring expertise and a comprehensive understanding of biological products, positioning us as a trusted partner in advancing life sciences research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.